How Does Age Affect Egg Quality and What Can You Do About It?

Age affects fertility more directly than most other factors, and in the consultations we have with patients, it’s one of the first variables we discuss. We don’t treat it as a background variable to address later. It shapes how we read test results and how we frame every treatment option from the first appointment on.

At Chedid Grieco, the patients who come to us with questions about age and egg quality span a wide range. Some are in their early 30s and planning ahead. Others arrive in their late 30s or 40s, and a sense of time pressure is usually already part of what they’re bringing into the appointment. Consultations happen at our Miami office and treatment takes place at our FDA- and NYDH-licensed facility in Sao Paulo, Brazil. For a full look at the treatments we offer, our treatments page has the detail.

What We See Happening to Reserve and Quality Over Time

Women are born with the full set of eggs they will ever have, somewhere around one to two million at birth. By puberty, that number has already dropped to roughly 300,000, and the attrition continues from there. Each month, a cohort of eggs begins maturing, though typically only one reaches release. What we see in practice is that by the mid-30s, most patients are dealing with both fewer eggs and a higher share that carry chromosomal irregularities.

The quality issue tends to be the more consequential of the two, and this surprises patients who’ve been focused primarily on reserve numbers. The longer eggs sit in the ovaries before ovulation, the more opportunity there is for accumulated DNA damage. That damage raises the rate of errors when the cell goes through division. The outcomes we see from those errors are mostly either fertilization that doesn’t complete, or embryos that show chromosomal concerns when we test them. We’re deliberate about addressing both reserve and quality because we’ve seen plenty of consultations where a patient’s reserve numbers were acceptable and quality was still what was driving the outcome.

How We Factor Age Into Treatment

We see the effect of age across every stage of assisted reproduction. Patients we see in their late 20s or early 30s respond more readily to stimulation and tend to retrieve more eggs per retrieval. The eggs also fertilize at higher rates. That consistency is why age is one of the first variables we factor when estimating what a treatment cycle is likely to look like for a specific patient.

The shift becomes more apparent after 35. In the 35 to 37 range, own-egg cycles generally still produce results we can work with. After 40, we see more significant drops, and we go through those numbers directly with patients rather than softening them. We’ve found that patients are better served by actual numbers they can plan around.

When we ask about lifestyle factors in the consultation, it’s because we’ve seen enough situations where something modifiable was affecting outcomes that we address it routinely. We ask about smoking specifically because the research ties it to faster depletion of ovarian reserve, which means a patient is often starting from a more depleted position than their age alone would suggest. Weight changes that are significant in either direction disrupt the hormonal environment in ways we see show up in how patients respond to treatment. We raise these when relevant because adjusting them before a cycle has made a difference in cases we’ve handled often enough to be worth the conversation.

What We Discuss on Nutrition and Supplements

We can’t undo what aging does to eggs, but we work with patients on optimizing the conditions around whatever eggs they have. On the nutrition side, diets high in antioxidant-rich foods come up regularly in these conversations because the evidence behind them for protecting eggs from oxidative damage is solid enough to act on. When patients ask what dietary changes are worth making before treatment, this is where we start.

In supplement conversations, Coenzyme Q10 comes up most often because of its role in mitochondrial function in eggs. Vitamin D is worth checking and correcting when it’s low, which turns up frequently in this patient group and has been tied to worse outcomes in the literature we follow. Folate comes up regardless of what else a patient is already taking, given its role in DNA synthesis. We consistently advise patients to bring their supplement list to us before starting anything new, because there are real contraindications at specific points in treatment that matter.

The basics also make a difference. In consultations with patients who’ve maintained consistent sleep and regular physical activity, we tend to see more stable hormone levels when we run labs. We see it often enough that it’s worth mentioning when patients ask what else they can do.

When Donor Eggs Enter the Conversation

We discuss egg donation when diminished ovarian reserve or significantly compromised quality makes a successful cycle with a patient’s own eggs unlikely. The chromosomal profile of donor eggs is tied to the donor’s age at retrieval, not to how old the recipient is. That’s why success rates with donor eggs stay more consistent across a wider range of recipient ages, including patients for whom own-egg cycles have already shown diminishing returns. For patients who’ve been through cycles with their own eggs, this can be a difficult transition, and we try to make space for that part of the conversation.

What preimplantation genetic diagnosis adds is a selection layer before transfer. Rather than proceeding without chromosomal information, we choose embryos that have tested accurately. For older patients specifically, where a higher proportion of embryos will show chromosomal errors and where each cycle represents a significant commitment, the difference between selecting in versus transferring without that information affects outcomes meaningfully.

How We Handle Preservation Timing

Preservation timing comes into the consultation even when a patient hasn’t arrived asking about it. For patients who aren’t ready for active treatment yet, we’d rather raise the question early enough that the answer is still clearly favorable, because that window closes earlier than most people expect. We go through timing concretely based on where a patient actually is, not just as a general case for why freezing is worth considering.

Whether you’re exploring fertility tourism as a path to more affordable treatment, or you’re just beginning to understand your options, our team gives patients a direct picture of where they stand. Contact us to schedule your consultation in Miami.